BIRC5 and cancer: Several studies conducted in the past have mainly focused on the polymorphisms in the promoter region of the BIRC5 gene such as –31 G/C, a single nucleotide polymorphism at the promoter region (SNP: −31 G/C) that was shown to alter the binding sites for CDE/CHR, thus inducing survivin overexpression in these cancers.